|
Gene id |
100132285 |
| Gene Summary Protein Summary Gene ontology KEGG pathways Diseases PubMed |
Gene Summary
|
|
Gene Symbol |
KIR2DS2 Gene UCSC Ensembl |
|
Aliases |
183ActI, CD158J, CD158b, KIR-2DS2, NKAT-5, NKAT5, cl-49 |
|
Gene name |
killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 2 |
|
Alternate names |
killer cell immunoglobulin-like receptor 2DS2, CD158 antigen-like family member J, MHC class I NK cell receptor, NK receptor 183 ActI, killer cell immunoglobulin-like receptor KIR2DS2, killer cell immunoglobulin-like receptor, two domains, short cytoplasm, |
|
Gene location |
19q13.4 (: ) Exons:
|
|
Gene summary(Entrez) |
Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the
|
|
OMIM |
604953 |
Protein Summary
|
| Protein general information
| P43631
Name: Killer cell immunoglobulin like receptor 2DS2 (CD158 antigen like family member J) (MHC class I NK cell receptor) (NK receptor 183 ActI) (Natural killer associated transcript 5) (NKAT 5) (p58 natural killer cell receptor clone CL 49) (p58 NK receptor CL 4
Length: 304 Mass: 33,502
|
| Sequence |
MSLMVVSMACVGFFLLQGAWPHEGVHRKPSLLAHPGPLVKSEETVILQCWSDVRFEHFLLHREGKYKDTLHLIGE HHDGVSKANFSIGPMMQDLAGTYRCYGSVTHSPYQLSAPSDPLDIVITGLYEKPSLSAQPGPTVLAGESVTLSCS SRSSYDMYHLSREGEAHERRFSAGPKVNGTFQADFPLGPATHGGTYRCFGSFRDSPYEWSNSSDPLLVSVTGNPS NSWPSPTEPSSKTGNPRHLHVLIGTSVVKIPFTILLFFLLHRWCSNKKNAAVMDQEPAGNRTVNSEDSDEQDHQE VSYA
|
| Structural information |
|
| Other Databases |
GeneCards: KIR2DS2  Malacards: KIR2DS2 |
|
| GO accession | Term name | Evidence code | Go category |
|---|
| GO:0004888 |
transmembrane signaling r eceptor activity
|
NAS |
molecular function |
GO:0005886 |
plasma membrane
|
TAS |
cellular component |
GO:0005886 |
plasma membrane
|
TAS |
cellular component |
GO:0006955 |
immune response
|
NAS |
biological process |
GO:0007165 |
signal transduction
|
IEA |
biological process |
GO:0016021 |
integral component of mem brane
|
NAS |
cellular component |
GO:0045087 |
innate immune response
|
TAS |
biological process |
GO:0050776 |
regulation of immune resp onse
|
TAS |
biological process |
GO:0004888 |
transmembrane signaling r eceptor activity
|
NAS |
molecular function |
GO:0005886 |
plasma membrane
|
IEA |
cellular component |
GO:0005886 |
plasma membrane
|
IEA |
cellular component |
GO:0005886 |
plasma membrane
|
TAS |
cellular component |
GO:0005886 |
plasma membrane
|
TAS |
cellular component |
GO:0006955 |
immune response
|
NAS |
biological process |
GO:0007165 |
signal transduction
|
IEA |
biological process |
GO:0016020 |
membrane
|
IEA |
cellular component |
GO:0016021 |
integral component of mem brane
|
IEA |
cellular component |
GO:0016021 |
integral component of mem brane
|
NAS |
cellular component |
GO:0045087 |
innate immune response
|
TAS |
biological process |
GO:0050776 |
regulation of immune resp onse
|
TAS |
biological process |
GO:0004888 |
transmembrane signaling r eceptor activity
|
NAS |
molecular function |
GO:0005886 |
plasma membrane
|
TAS |
cellular component |
GO:0005886 |
plasma membrane
|
TAS |
cellular component |
GO:0006955 |
immune response
|
NAS |
biological process |
GO:0016021 |
integral component of mem brane
|
NAS |
cellular component |
GO:0045087 |
innate immune response
|
TAS |
biological process |
GO:0050776 |
regulation of immune resp onse
|
TAS |
biological process |
|
|
| Pathway id | Pathway name |
| hsa00480 | Glutathione metabolism | | hsa00512 | Mucin type O-glycan biosynthesis | | hsa04650 | Natural killer cell mediated cytotoxicity | | hsa04612 | Antigen processing and presentation | |
|
| Associated diseases |
References |
| Cancer (Hepatocellular) | GAD: 19326408 |
| Cancer (leukemia) | GAD: 19450876 |
| Cancer (lymphoma) | GAD: 20207982 |
| Cancer (Neuroblastoma) | GAD: 19934297 |
| Cardiovascular disease | GAD: 18755860 |
| Graves disease | GAD: 19664392 |
| Chorioretinitis | GAD: 18340360 |
| Arthritis | GAD: 17882223 |
| Behcet's disease | GAD: 17868255 |
| Ulcerative colitis | GAD: 16929347 |
| Rheumatoid arthritis | GAD: 11369787 |
| Multiple sclerosis | GAD: 19421224 |
| Scleroderma | GAD: 20082621 |
| Psoriasis | GAD: 18681957 |
| Psoriatic arthritis | GAD: 16112031 |
| Systemic lupus erythematosus (SLE) | GAD: 17445179 |
| Systemic lupus erythematosus (SLE) | GAD: 18687225 |
| Autoimmune diseases | GAD: 20082482 |
| Axial spondyloarthropathy | GAD: 19850842 |
| Diabetes | GAD: 14514651 |
| Osteoarthritis | GAD: 19489269 |
| Osteoarthritis | GAD: 19489269 |
| Ankylosing spondylitis | GAD: 19019897 |
| Paraparesis | GAD: 20483367 |
| Uveomeningoencephalitic syndrome | GAD: 18571006 |
| Vogt-Koyanagi-Harada syndrome | GAD: 19897003 |
| Abortion | GAD: 20210919 |
| Pregnancy loss | GAD: 19279038 |
| Spontaneous abortion | GAD: 19875891 |
| Cryptorchidism | MIK: 26679162 |
| Cryptorchidism | MIK: 26679162 |
|
|
| PMID |
Condition |
Mutation |
Ethnicity |
Population details |
Infertility_type |
Associated_genes |
Abstract |
| 26679162 |
Cryptorchi dism
|
|
|
245 (109 prepub ertal boys with cryptorchidism , 136 ethnicall y matched young male donors)
|
Male infertility |
|
Show abstract |
|